Literature DB >> 18031528

Doppler-guided intra-operative fluid management during major abdominal surgery: systematic review and meta-analysis.

S R Walsh1, T Tang, S Bass, M E Gaunt.   

Abstract

BACKGROUND: Peri-operative fluid therapy is a controversial area with few randomised trials to guide practice. Recently, a number of trials have suggested that intra-operative therapy guided by oesophageal Doppler acquired haemodynamic variables may improve postoperative outcome.
METHODS: Abstract databases and conference proceedings were searched to identify randomised controlled trials comparing Doppler-guided intra-operative fluid management to standard practice in patients undergoing major abdominal surgery. Pooled odds ratios (POR) and weighted mean differences (WMD) were calculated for categorical and continuous outcomes respectively.
RESULTS: Four trials, comprising 393 patients, were identified. Use of an oesophageal Doppler-guided fluid management algorithm resulted in fewer postoperative complications (POR 0.32; 95% CI: 0.19-0.52; p < 0.0001) and shorter hospital stays (WMD 1.68 days; 95% CI: 2.39-0.98; p < 0.0001). There were no significant differences in the quantities of intra-operative fluids administered although there was some evidence of heterogeneity with respect to this outcome.
CONCLUSION: Oesophageal Doppler-guided fluid management may improve outcome following major intra-abdominal surgery. However, comparison with fluid restriction strategies, including a cost-effectiveness analysis are required.

Entities:  

Mesh:

Year:  2007        PMID: 18031528     DOI: 10.1111/j.1742-1241.2007.01516.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  14 in total

1.  Fast-track for the modern colorectal department.

Authors:  Rishabh Sehgal; Arnold Hill; Joseph Deasy; Deborah A McNamara; Ronan A Cahill
Journal:  World J Surg       Date:  2012-10       Impact factor: 3.352

Review 2.  [Haemodynamic monitoring in the perioperative phase. Available systems, practical application and clinical data].

Authors:  U Wittkowski; C Spies; M Sander; J Erb; A Feldheiser; C von Heymann
Journal:  Anaesthesist       Date:  2009-08       Impact factor: 1.041

Review 3.  [Goal-directed hemodynamic therapy: Concepts, indications and risks].

Authors:  S A Haas; B Saugel; C J Trepte; D A Reuter
Journal:  Anaesthesist       Date:  2015-07       Impact factor: 1.041

Review 4.  New perioperative fluid and pharmacologic management protocol results in reduced blood loss, faster return of bowel function, and overall recovery.

Authors:  Patrick Y Wuethrich; Fiona C Burkhard
Journal:  Curr Urol Rep       Date:  2015-04       Impact factor: 3.092

5.  Hemodynamic monitoring development: helpful technology or expensive luxury?

Authors:  Karim Bendjelid
Journal:  J Clin Monit Comput       Date:  2012-10       Impact factor: 2.502

6.  Perioperative Fluid Administration in Pancreatic Surgery: a Comparison of Three Regimens.

Authors:  Leonardo Gottin; Alvise Martini; Nicola Menestrina; Vittorio Schweiger; Giuseppe Malleo; Katia Donadello; Enrico Polati
Journal:  J Gastrointest Surg       Date:  2019-04-03       Impact factor: 3.452

Review 7.  Perioperative fluid restriction.

Authors:  Joshua I S Bleier; Cary B Aarons
Journal:  Clin Colon Rectal Surg       Date:  2013-09

8.  Perioperative fluid and volume management: physiological basis, tools and strategies.

Authors:  Mike S Strunden; Kai Heckel; Alwin E Goetz; Daniel A Reuter
Journal:  Ann Intensive Care       Date:  2011-03-21       Impact factor: 6.925

9.  Non-Invasive Wearable Patch Utilizing Seismocardiography for Peri-Operative Use in Surgical Patients.

Authors:  Beren Semiz; Andrew M Carek; Jessica C Johnson; Shireen Ahmad; J Alex Heller; Florencia G Vicente; Stacey Caron; Charles W Hogue; Mozziyar Etemadi; Omer T Inan
Journal:  IEEE J Biomed Health Inform       Date:  2021-05-11       Impact factor: 5.772

Review 10.  Clinical review: What are the best hemodynamic targets for noncardiac surgical patients?

Authors:  Suzana Margareth Lobo; Neymar Elias de Oliveira
Journal:  Crit Care       Date:  2013-03-19       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.